TD Cowen analyst Brendan Smith downgraded Passage Bio Inc. (NASDAQ: PASG) from Buy to Hold.The analyst comments "PASG released updated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE